Literature DB >> 10778890

Laryngeal synkinesis revisited.

R L Crumley1.   

Abstract

First described in 1982, laryngeal synkinesis continues to play an important diagnostic and therapeutic role following recurrent laryngeal nerve (RLN) injury. Vocal fold motion impairment (formerly called "vocal cord paralysis"), hyperadducted and hyperabducted vocal folds, and certain laryngeal spasmodic and tremor disorders are often best explained by synkinesis. A closer look at these mechanisms confirms that following RLN injury, immobile vocal folds may be nearly normally functional (favorable), or spastic, hyperadducted, or hyperabducted (unfavorable). This has resulted in a functional classification of laryngeal synkinesis as follows: type I laryngeal synkinesis, with satisfactory voice and airway (vocal fold poorly mobile, or immobile); type II synkinesis, with spasmodic vocal folds and an unsatisfactory voice and/or airway; type III synkinesis, with hyperadducted vocal folds and airway compromise; and type IV synkinesis, with hyperabducted vocal folds, poor voice, and possible aspiration. This classification facilitates the understanding of laryngeal pathophysiology following RLN injuries and promotes a more scientific basis for management.

Entities:  

Mesh:

Year:  2000        PMID: 10778890     DOI: 10.1177/000348940010900405

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  45 in total

1.  A system for studying facial nerve function in rats through simultaneous bilateral monitoring of eyelid and whisker movements.

Authors:  James T Heaton; Jeffrey M Kowaleski; Roberto Bermejo; H Philip Zeigler; David J Ahlgren; Tessa A Hadlock
Journal:  J Neurosci Methods       Date:  2008-03-22       Impact factor: 2.390

Review 2.  Recovery of laryngeal function after intraoperative injury to the recurrent laryngeal nerve.

Authors:  Per Mattsson; Jonas Hydman; Mikael Svensson
Journal:  Gland Surg       Date:  2015-02

3.  Functional outcomes of endoscopic arytenoid abduction lateropexy for unilateral vocal cord paralysis with dyspnea.

Authors:  Vera Matievics; Adam Bach; Balazs Sztano; Zsofia Bere; Zoltan Tobias; Paul F Castellanos; Andreas H Mueller; Laszló Rovo
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-08-08       Impact factor: 2.503

4.  Neurotrophic factor-secreting autologous muscle stem cell therapy for the treatment of laryngeal denervation injury.

Authors:  Stacey L Halum; Bryan McRae; Khadijeh Bijangi-Vishehsaraei; Kelly Hiatt
Journal:  Laryngoscope       Date:  2012-09-10       Impact factor: 3.325

5.  Functional regeneration of recurrent laryngeal nerve injury during thyroid surgery using an asymmetrically porous nerve guide conduit in an animal model.

Authors:  Jeong-Seok Choi; Se Heang Oh; Hye-Young An; Young-Mo Kim; Jin Ho Lee; Jae-Yol Lim
Journal:  Thyroid       Date:  2013-11-06       Impact factor: 6.568

6.  Diagnosis and management with botulinum toxin in 11 cases of laryngeal synkinesis.

Authors:  Asier Lekue; Isabel García-López; Susana Santiago; Antonio Del Palacio; Javier Gavilán
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-26       Impact factor: 2.503

7.  Differentiating arytenoid dislocation and recurrent laryngeal nerve paralysis by arytenoid movement in laryngoscopic video.

Authors:  Peiyun Zhuang; Steven Nemcek; Ketan Surender; Matthew R Hoffman; Fan Zhang; William J Chapin; Jack J Jiang
Journal:  Otolaryngol Head Neck Surg       Date:  2013-05-29       Impact factor: 3.497

8.  Reorganization of laryngeal motoneurons after crush injury in the recurrent laryngeal nerve of the rat.

Authors:  Ignacio Hernández-Morato; Francisco J Valderrama-Canales; Gabriel Berdugo; Gonzalo Arias; Stephen McHanwell; José Sañudo; Teresa Vázquez; Arán Pascual-Font
Journal:  J Anat       Date:  2013-02-27       Impact factor: 2.610

9.  Diagnosis and management of unilateral thyroarytenoid muscle palsy.

Authors:  Ujimoto Konomi; Ryoji Tokashiki; Hiroyuki Hiramatsu; Masanobu Kumada
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-24       Impact factor: 2.503

10.  Botulinum toxin injection in laryngeal dyspnea.

Authors:  Virginie Woisard; Xuelai Liu; Marie Christine Arné Bes; Marion Simonetta-Moreau
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-06       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.